J Korean Dysphagia Soc.  2018 Jul;8(2):57-66. 10.0000/jkdps.2018.8.2.57.

Radiotherapy in the Region of the Head and Neck and the Consequential Changes in Normal Tissues

Affiliations
  • 1Department of Radiation Oncology, Kangdong Sacred Heart Hospital, College of Medicine, University of Hallym, Seoul, Korea. hantz@hallym.or.kr

Abstract

Radiotherapy is a crucial non-surgical modality for head and neck cancer. With increasing radiation dose, the possibility of tumor control increases but the probability of toxicity to the surrounding normal tissue also increases. The subsequent changes in the normal tissues after radiotherapy can occur within a few minutes, or even several years. The early effects occur in rapidly proliferating tissue and tend to cause inflammation and are usually reversible. The late effects occur in more slowly proliferating tissues and the pathogenesis includes fibrosis, atrophy, and vascular damage. The early and late responses of the normal tissue can be dose-limiting factors in radiotherapy for head and neck cancer, affecting the therapeutic efficacy and quality of life of cancer survivors. Radiation-induced oral mucositis is the major limiting acute toxicity of radiotherapy for head and neck cancers and can lead to treatment interruption and suboptimal disease control. On the other hand, the most problematic late toxicities in the region of the head and neck are decreased secretion of saliva and dysfunction in swallowing. This review investigated the pathophysiology of radiation-induced toxicity: oral mucositis, xerostomia and dysphagia.

Keyword

Head and neck cancer; Radiotherapy; Toxicity; Quality of life

MeSH Terms

Atrophy
Deglutition
Deglutition Disorders
Fibrosis
Hand
Head and Neck Neoplasms
Head*
Humans
Inflammation
Neck*
Quality of Life
Radiotherapy*
Saliva
Stomatitis
Survivors
Xerostomia
Full Text Links
  • JKDPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr